The change is in response to written comments submitted by the staff of the Joint Administrative Procedures Committee. The changes are as follows:
1. Subsection (1) shall now read as follows:
(1) All applications for licensure by endorsement shall be made on board approved form DOH/MQA/PH100 (Rev.01/2009), The instructions and application form, entitled Florida Pharmacist Licensure by Endorsement Application and Instructions, which is hereby incorporated by reference, can be obtained from the Board of Pharmacy, 4052 Bald Cypress Way, Bin #C04, Tallahassee, Florida 32399-3254, and shall be accompanied with a non-refundable endorsement application fee and initial license fee set forth in Rules 64B16-26.1001 and 64B16-26.1002, F.A.C.
2. Subsection (2) shall now read as follows:
(2) The applicant must submit satisfactory proof that one of the following requirements has been met:
(a) Two (2) years of active practice, as defined in Section 465.0075(1)(c), F.S., within the immediately preceding five (5) years. If the applicant meets the requirements of this section, proof of completion of 30 hours of Florida Board of Pharmacy, ACPE, or other state board of pharmacy approved continuing education obtained in the two years immediately preceding application, must be submitted.
(b) Successful completion of an internship meeting the requirements of Section 456.007(1)(c), F.S., within the immediately preceding two (2) years.
3. Subsection (3) shall now read as follows:
(3) The applicant must submit satisfactory proof of completion of the following:
A course of no less than two (2) hours on medication errors covering the subjects set forth in Rule 64B16-26.103, F.A.C. The course shall be completed no earlier than 12 months prior to application.
4. Subsection (8) shall now read as follows:
(8) Applicants deemed qualified for licensure by endorsement shall be required to complete the Multistate Pharmacy Jurisprudence Examination – Florida Version. Passing scores on this examination may be used upon reapplication only if the examination was completed within three (3) years of the reapplication.
THE PERSON TO BE CONTACTED REGARDING THE PROPOSED RULE IS: Rebecca Poston, Executive Director, Board of Pharmacy, 4052 Bald Cypress Way, Bin #C04, Tallahassee, Florida 32399-3254.